HOME >> BIOLOGY >> NEWS
Jefferson scientists show drug is effective against a Hepatitis C Virus model in the laboratory

Glucosidase inhibitors may have a future as broad-based hepatitis drugs Researchers at Jefferson Medical College may have found a promising drug against the hepatitis C virus (HCV). While they are quick to point out that the drug, N-nonyl-DNJ, stopped only a surrogate virus - and not the actual HCV - from reproducing in the laboratory, they believe the findings, which build on their earlier success against hepatitis B virus (HBV), may someday lead to a single drug against both viruses.

Timothy Block, Ph.D., professor of biochemistry and molecular pharmacology and medicine at Thomas Jefferson University in Philadelphia, and colleagues at Oxford University in Oxford, UK, used the drug to inhibit the activity of an important cellular enzyme, glucosidase. This in turn prevented the bovine diarrhea virus, BVDV, which is a tissue culture model of HCV, from making more virus. Dr. Block believes this class of drugs, called glucosidase inhibitors, "have a reasonable likelihood of working against HCV therapeutically." Because HCV cannot be grown in the lab, researchers use BVDV as a testing model.

"This is the first drug since alpha-interferon to my knowledge for which there is published experimental evidence against HCV - in the form of BVDV susceptibility," says Dr. Block, who is a member of Jefferson's Kimmel Cancer Center and director of the Jefferson Center for Biomedical Research and Agricultural Medicine.

The drug may sidestep resistant viruses, the bane of current anti-hepatitis treatments. "Since the drugs target a host cellular enzyme at very non-toxic doses, rather than the virus, we think that resistance to the drugs will not be a problem,"he says.

The findings appear Oct. 12 in the Proceedings of the National Academy of Sciences. Viruses such as HCV, HBV and BVDV reproduce by actually "budding out from intracellular membranes." The viruses
'"/>

Contact: Steve Benowitz
steven.benowitz@mail.tju.edu
215-955-5291
Thomas Jefferson University
11-Oct-1999


Page: 1 2 3

Related biology news :

1. Jefferson Lab detector technology aids development of cystic fibrosis therapy
2. Jefferson scientists find gene expression pattern may predict behavior of leukemia
3. Jefferson researchers develop microchip to track genetic signature of cancer and normal tissue
4. Jefferson scientists use gene therapy to restore function of damaged heart cells in lab
5. Jefferson researchers uncover biochemical clues to how cells migrate in embryos
6. Jefferson and Brigham and Womens researchers find blue light important for setting biological clock
7. Jefferson Lab experiment generates THz radiation 20,000 times brighter than anyone else
8. Jefferson scientists show neural stem cells can become dopamine-making brain cells in laboratory
9. Jefferson scientists show how collagen gene mutation leads to osteoarthritis
10. Jefferson scientists use gene repair technique to change albino mice hairs to black
11. Jefferson scientists propose mechanism to control the bodys red blood cell and platelet production

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/28/2020)... ... February 26, 2020 , ... ... Rebound PRF® devices are now available to veterinary practices through Covetrus. Enso ... that will provide the most affordable, easiest to use, multi-species validated, platelet-rich ...
(Date:2/28/2020)... SCOTTSDALE, Ariz. (PRWEB) , ... February 27, 2020 , ... ... PDO Max. The first rate PDO thread lift products are not only ... the portfolio. , Non invasive thread lift procedures are increasing exponentially in popularity, as ...
(Date:2/28/2020)... ... 2020 , ... Regen Suppliers is now offering first time ... cell and exosome biologics. , Regen Suppliers offers an extensive variety of regenerative ... PDO thread lifts and more. The company is truly a one stop ...
Breaking Biology News(10 mins):
(Date:2/19/2020)... ... February 18, 2020 , ... ... microbiome populations down to the strain level, recently unveiled a novel DNA isolation ... efficient and unbiased isolation of high molecular weight (HMW) single-stranded DNA (ssDNA) in ...
(Date:2/19/2020)... ... February 19, 2020 , ... Red ... life sciences industry, today announced the opening of a new office in Tokyo, ... Nucleus R&D. , Red Nucleus announced the new office in response to customer ...
(Date:2/11/2020)... ... February 11, 2020 , ... ... results from a long-term follow-up clinical study of outpatient L4-L5 lumbar interspinous ... LLC). Unlike extension block design, the Inspan device fixates the spine to ...
(Date:2/10/2020)... LAS VEGAS (PRWEB) , ... February 10, 2020 , ... ... Cell Training Course March 13-14th, 2020 in Las Vegas. The course is hands ... procedure too. , For the past few years, the Comprehensive Stem Cell Training Course ...
Breaking Biology Technology:
Cached News: